Valeant regains some recent losses after Philidor restatement details announced

LAVAL, Que. -- Valeant Pharmaceuticals shares got a positive bounce Tuesday after the company announced that its restatement of financial results for 2014 and 2015 involve just US$58 million of sales to Philidor were recognized at the wrong time.

See Full Article

The Quebec-based company said late Monday that it should have recognized the revenue when the products were dispensed to patients, rather than when delivered to Philidor -- an associated company that sold some Valeant drugs.

The stock (TSX:VRX) was at $110.94 shortly after the Toronto Stock Exchange opened, a gain of $6.78 or 6.5 per cent from Monday's close.

The stock had fallen more than $25 per share in the previous three sessions, including $12.84 on Monday amid news reports that a financial restatement was in the works.

Valeant said it estimates that its 2014 earnings will be reduced by 10 cents per share, in U.S. currency, and 2015 earnings will be increased by nine cents per share.

The amounts involved with the Philidor restatement are tiny compared with Valeant's total revenue and profit in 2014. It reported US$8.3 billion of revenue and $1.56 per share of earnings for the 12 months ended Dec. 31, 2014.

At least one analyst said the selloff was overdone, if it is based on concerns over the delayed release of fourth-quarter earnings as a result of the restatement.

"On an ongoing basis, we believe Philidor risk is mostly mitigated (except for potential penalties etc)," Douglas Miehm of RBC Capital Markets wrote in a report.

He said the successful implementation of a program with Walgreens to replace Philidor satisfies operational concerns. Walgreens is one of the biggest pharmacy retail chains in the United States.

Apart from the disruption caused by any financial restatement by a publicly traded company, Valeant is coping with a previous controversy that erupted last fall when questions were raised about its relationship with Philidor Rx Services.

Valeant's shares fell from $148.66 to $118.61 in heavy trading on Oct. 21. The stock has continued to trade below those levels and hit a 52-week intraday low of US$69.33 in New York on Nov. 18.

Valeant said on Oct. 30 that it had severed ties with the Pennsylvania-based online specialty pharmacy company after reviewing its practices. Philidor subsequently announced that it would cease operations.



Advertisements

Latest Economic News

  • Trump will zero in on trade agreements during 100th day

    Economic CTV News
    WASHINGTON -- U.S. President Donald Trump will spend his 100th day in office talking tough on trade in one of the states that delivered his unlikely win. The president is expected to sign an executive order Saturday that will direct his Commerce Department and the U.S. Source
  • B.C. leader could drag Canada into unwanted battle with U.S. on softwood: expert

    Economic CTV News
    BURNABY, B.C. -- A vow by British Columbia's Liberal leader to fight American tariffs on softwood lumber may force the federal government to wage an unwanted battle with the United States, an international trade expert says. Source
  • Hacker threatens to release stolen copies of Netflix series

    Economic CTV News
    SAN FRANCISCO -- A hacker claims to have stolen the upcoming season of Netflix's hit series "Orange Is The New Black," and is asking for an unspecified ransom to not release the entire fifth season online. Source
  • Bombardier faces lengthy legal battle with Boeing that could hurt CSeries sales

    Economic CBC News
    Bombardier faces a lengthy legal battle with Boeing after the aerospace giant filed a complaint with the U.S. government and the process could hurt sales of the new CSeries commercial jet, say trade experts and industry analysts. Source
  • Bombardier faces lengthy legal battle with Boeing that may hurt CSeries sales

    Economic CTV News
    MONTREAL -- Bombardier faces a lengthy legal battle with Boeing after the aerospace giant filed a complaint with the U.S. government and the process could hurt sales of the new CSeries commercial jet, say trade experts and industry analysts. Source
  • Home Capital troubles may translate to higher interest rates for some borrowers

    Economic CTV News
    TORONTO -- Troubles at Home Capital Group may translate to higher mortgage rates for less creditworthy borrowers if concerns about the sector increase funding costs for other subprime lenders, experts say. "Inevitably this will likely effect all lenders in the alternative space as it puts the spotlight on the risk, and questions the integrity of some of the mortgages they are lending on," said Steve Pipkey co-founder of Vancouver-based Spin Mortgage. Source
  • Canada restarts free trade negotiations with South American trading bloc

    Economic CBC News
    Canada's hectic international trade agenda is about to get even busier, as it takes new steps toward formal free trade negotiations with Mercosur, the trading bloc that includes the key South American markets of Argentina, Brazil, Paraguay and Uruguay, CBC News has learned. Source
  • Canada restarts free trade negotiations with South America's Mercosur trading bloc

    Economic CBC News
    Canada's hectic international trade agenda is about to get even busier, as it takes new steps toward formal free trade negotiations with Mercosur, the trading bloc that includes the key South American markets of Argentina, Brazil, Paraguay and Uruguay, CBC News has learned. Source
  • Imperial Oil not idle amidst oilsands dealmaking, says CEO

    Economic CBC News
    Imperial Oil is reporting first-quarter earnings that reversed a loss in the same period of last year but fell short of analyst expectations. The Calgary-based oil producer and refiner says net income was $333 million or 39 cents per share in the three months ended March 31, boosted by a gain of $151 million on the sale of former refinery lands in Mississauga, Ont. Source
  • Imperial Oil posts first-quarter profit but falls short of forecasts

    Economic CBC News
    Imperial Oil is reporting first-quarter earnings that reversed a loss in the same period of last year but fell short of analyst expectations. The Calgary-based oil producer and refiner says net income was $333 million or 39 cents per share in the three months ended March 31, boosted by a gain of $151 million on the sale of former refinery lands in Mississauga, Ont. Source